Short answer
PUMA BIOTECHNOLOGY, INC. (PBYI) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q2 2026 results for quarter ended June 30, 2026, furnished through Exhibit 99.1.
PUMA BIOTECHNOLOGY, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026, furnished through Exhibit 99.1
- Exhibit 99.1 contains the substantive financial results and management commentary for investor review
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PUMA BIOTECHNOLOGY, INC. 8-K filings
Get the next PBYI 8-K as it lands
Follow PBYI for push alerts, or ask the research agent what this filing means.